Ronapreve

Made by

• Chugai (Roche)

Active Ingredient

Casirivimab (genetical recombination) and imdevimab (genetical recombination)

Approval date

2021/7/19

Treats

• COVID-19

Dosages

• ロナプリーブ点滴静注セット300 -

• ロナプリーブ点滴静注セット1332 -